Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for SQZ Biotechnologies Co's 14-Day RSI or its related term are showing as below:
SQZB's 14-Day RSI is not ranked
in the Biotechnology industry.
Industry Median: 42.84
vs SQZB: 47.91
SQZ Biotechnologies Co (OTCPK:SQZB) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
SQZ Biotechnologies Co 14-Day RSI Related Terms
SQZB vs AGTX, ISCO, VYNT: 14-Day RSI Comparison
For the Biotechnology subindustry, SQZ Biotechnologies Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SQZ Biotechnologies Co 14-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SQZ Biotechnologies Co's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where SQZ Biotechnologies Co's 14-Day RSI falls into.
SQZ Biotechnologies Co (OTCPK:SQZB) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SQZ Biotechnologies Co (SQZB) has a 14-Day RSI of 47.91 as of Jul. 30, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on SQZ Biotechnologies Co and its competitors.
Is SQZ Biotechnologies Co's 14-Day RSI too high?
SQZ Biotechnologies Co's current 14-Day RSI is 47.91. The Biotechnology industry median 14-Day RSI is 42.84. SQZ Biotechnologies Co's value of 47.91 is 11.8% above this industry median. Overall, SQZ Biotechnologies Co has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SQZ Biotechnologies Co's 14-Day RSI compare to AGTX and ISCO?
SQZ Biotechnologies Co's 14-Day RSI of 47.91 can be compared against companies in the Biotechnology industry. The industry median 14-Day RSI is 42.84. SQZ Biotechnologies Co's value of 47.91 is 11.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Biotechnology company?
The median 14-Day RSI among Biotechnology companies is 42.84, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SQZ Biotechnologies Co's current 14-Day RSI of 47.91 is 11.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on SQZ Biotechnologies Co and its competitors. For the Biotechnology industry, the median 14-Day RSI is 42.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SQZ Biotechnologies Co's current 14-Day RSI is 47.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SQZ Biotechnologies Co stock overvalued right now?
SQZ Biotechnologies Co (SQZB) has a current 14-Day RSI of 47.91. The current 14-Day RSI is 47.91 and 11.8% above the Biotechnology industry median of 42.84. SQZ Biotechnologies Co's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For SQZ Biotechnologies Co (SQZB), the current 14-Day RSI is 47.91 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
12GF Score
Get the complete analysis for SQZB
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SQZB has been successfully added to your 
